CDMO Perspective on Clinical Supply Planning for Studies with Unconventional Timelines
Learn how unconventional trials impact the supply chain and the role a CDMO can play in facilitating these studies.
Planning Ahead: Using Phase 1 to Anticipate Phase 2 Clinical Supply
Learn what clinical sponsors should look for when assessing integrated services and potential providers.
Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials
How adopting the decentralized trial approach introduces new challenges for companies hoping to ramp up an early phase trial or keep later stage studies going during the pandemic.
Decentralization: A Direct Approach to Clinical Trials
The global pandemic provides an opportunity for the further decentralization of clinical trials, with direct-to-patient protocols reducing or eliminating the need for patients to travel to clinical sites and potentially expose themselves and others to a risk of infection.
Industry Perspective: Defining the Optimal Clinical Supply Strategy for Cell/Gene Therapy Studies
Insight into the current level of integration between the manufacturing and supply chain used and sought by cell/gene therapy companies.
Building a Flexible, Challenge Resistant and Patient Centric Clinical Supply Chain
Learn strategies to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges.